Free Trial

Evolus (EOLS) Short Interest Ratio & Short Volume

Evolus logo
$9.93 -0.25 (-2.46%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$9.94 +0.02 (+0.15%)
As of 06/13/2025 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evolus Short Interest Data

Evolus (EOLS) has a short interest of 9.67 million shares, representing 16.26% of the float (the number of shares available for trading by the public). This marks a 4.65% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.7, indicating that it would take 9.7 days of the average trading volume of 740,551 shares to cover all short positions.

Current Short Interest
9,670,000 shares
Previous Short Interest
9,240,000 shares
Change Vs. Previous Month
+4.65%
Dollar Volume Sold Short
$90.61 million
Short Interest Ratio
9.7 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
64,476,000 shares
Short Percent of Float
16.26%
Today's Trading Volume
1,068,138 shares
Average Trading Volume
740,551 shares
Today's Volume Vs. Average
144%
Short Selling Evolus?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Evolus and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EOLS Short Interest Over Time

EOLS Days to Cover Over Time

EOLS Percentage of Float Shorted Over Time

Evolus Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20259,670,000 shares $90.61 million +4.7%16.3%9.7 $9.37
5/15/20259,240,000 shares $92.40 million +5.7%15.5%10.3 $10.00
4/30/20258,740,000 shares $99.64 million +14.0%N/A10 $11.40
4/15/20257,670,000 shares $78.46 million +7.3%12.9%9.1 $10.23
3/31/20257,150,000 shares $86.01 million +1.4%12.0%8.5 $12.03
3/15/20257,050,000 shares $93.06 million +3.5%11.9%9 $13.20
2/28/20256,810,000 shares $99.36 million +3.8%11.5%9 $14.59
2/15/20256,560,000 shares $96.69 million +9.5%11.0%9.1 $14.74
1/31/20255,990,000 shares $83.68 million +1.0%N/A8 $13.97
1/15/20255,930,000 shares $59.72 million +9.8%N/A8.8 $10.07
12/31/20245,400,000 shares $59.62 million +4.3%N/A8.6 $11.04
12/15/20245,180,000 shares $59.62 million -0.6%N/A8.6 $11.51
11/30/20245,210,000 shares $71.32 million -1.5%N/A8.2 $13.69
11/15/20245,290,000 shares $64.06 million -2.6%N/A8.4 $12.11
10/31/20245,430,000 shares $88.62 million +8.8%N/A8.9 $16.32
10/15/20244,990,000 shares $83.33 million +3.1%N/A8.5 $16.70
9/30/20244,840,000 shares $78.41 million -0.8%N/A8.8 $16.20
9/15/20244,880,000 shares $85.35 million +2.3%N/A9 $17.49
8/31/20244,770,000 shares $75.80 million -1.0%N/A9.5 $15.89
8/15/20244,820,000 shares $65.55 million -4.4%N/A9.6 $13.60
7/31/20245,040,000 shares $62.60 million -4.0%N/A9.8 $12.42
7/15/20245,250,000 shares $63.37 million +10.5%9.7%9.8 $12.07
6/30/20244,750,000 shares $51.54 million +4.6%8.8%8.7 $10.85
6/15/20244,540,000 shares $51.44 million +2.0%8.4%8.3 $11.33
5/31/20244,450,000 shares $57.54 million -4.1%8.3%7.7 $12.93
5/15/20244,640,000 shares $61.43 million -2.9%8.6%7.4 $13.24
4/30/20244,780,000 shares $56.26 million +3.0%9.7%7.7 $11.77
4/15/20244,640,000 shares $55.17 million -0.2%9.6%8.1 $11.89
3/31/20244,650,000 shares $65.10 million -6.6%9.8%7.1 $14.00
3/15/20244,980,000 shares $69.22 million +0.4%10.5%7.7 $13.90
2/29/20244,960,000 shares $73.56 million +1.2%11.3%8.2 $14.83
2/15/20244,900,000 shares $67.47 million +2.9%11.1%8.1 $13.77
1/31/20244,760,000 shares $60.40 million +17.2%10.8%6.6 $12.69
1/15/20244,060,000 shares $42.83 million -7.3%9.2%5.4 $10.55
12/31/20234,380,000 shares $46.12 million -1.1%9.9%6.3 $10.53
12/15/20234,430,000 shares $43.86 million -9.0%10.0%6.5 $9.90
11/30/20234,870,000 shares $46.12 million -25.4%11.0%7.3 $9.47
11/15/20236,530,000 shares $58.18 million +60.8%14.8%10.2 $8.91
10/31/20234,060,000 shares $30.86 million +4.4%9.2%7.1 $7.60
10/15/20233,890,000 shares $31.66 million +1.3%8.8%6.5 $8.14
Banks aren’t ready for this altcoin—are you? (Ad)

Crypto Market In Rare Form For Rapid Wealth Building When you've been in crypto as long as I have, you learn to recognize the signs and right now, I'm seeing something that's keeping me up at night.

Discover our #1 crypto for the red-hot crypto market right now!
9/30/20233,840,000 shares $35.10 million +7.9%9.1%7.1 $9.14
9/15/20233,560,000 shares $33.61 million +5.3%8.4%6.2 $9.44
8/31/20233,380,000 shares $33.43 million -0.6%8.0%5.1 $9.89
8/15/20233,400,000 shares $34.68 million -21.7%8.1%5 $10.20
7/31/20234,340,000 shares $43.49 million -1.6%10.1%6.2 $10.02
7/15/20234,410,000 shares $32.63 million +24.6%10.3%7.8 $7.40
6/30/20233,540,000 shares $25.74 million +17.6%8.3%6.1 $7.27
6/15/20233,010,000 shares $23.15 million +7.1%7.1%5.6 $7.69
5/31/20232,810,000 shares $25.43 million -0.4%6.6%5.6 $9.05
5/15/20232,820,000 shares $29.10 million +2.2%6.6%6.4 $10.32
4/30/20232,760,000 shares $24.12 million +9.5%6.6%5.4 $8.74
4/15/20232,520,000 shares $21.14 million +4.1%6.0%4.8 $8.39
3/31/20232,420,000 shares $20.47 million +10.5%5.8%4.6 $8.46
3/15/20232,190,000 shares $18.75 million -0.9%5.2%4.1 $8.56
2/28/20232,210,000 shares $20.04 million -6.4%5.4%4.2 $9.07
2/15/20232,360,000 shares $22.11 million +6.3%5.8%4.5 $9.37
1/31/20232,220,000 shares $23.07 million -14.3%6.1%4.6 $10.39
1/15/20232,590,000 shares $22.40 million +0.4%7.0%6.2 $8.65
12/30/20222,580,000 shares $19.38 million +33.7%7.0%6.7 $7.51
12/15/20221,930,000 shares $13.55 million -15.4%5.2%4.8 $7.02
11/30/20222,280,000 shares $16.51 million -2.6%6.2%5.7 $7.24
11/15/20222,340,000 shares $17.64 million -8.2%6.3%5.7 $7.54
10/31/20222,550,000 shares $21.83 million -5.2%6.9%5.7 $8.56
10/15/20222,690,000 shares $22.41 million +24.0%7.3%5.2 $8.33
9/30/20222,170,000 shares $17.47 million +11.3%5.9%4.1 $8.05
9/15/20221,950,000 shares $19.81 million -5.3%5.3%3.9 $10.16
8/31/20222,060,000 shares $19.80 million -3.7%5.7%3.9 $9.61
8/15/20222,140,000 shares $20.24 million +6.5%6.0%4 $9.46
7/31/20222,010,000 shares $24.78 million -7.4%5.6%3.4 $12.33
7/15/20222,170,000 shares $27.80 million -8.1%6.1%4.3 $12.81
6/30/20222,360,000 shares $27.38 million -8.2%6.6%4.7 $11.60
6/15/20222,570,000 shares $30.40 million -13.2%7.2%5.1 $11.83
5/31/20222,960,000 shares $38.18 million -2.6%8.3%5.8 $12.90
5/15/20223,040,000 shares $40.07 million +22.1%8.5%6.2 $13.18
4/30/20222,490,000 shares $27.86 million +9.2%7.0%5.5 $11.19
4/15/20222,280,000 shares $25.72 million -1.7%6.4%4.7 $11.28
3/31/20222,320,000 shares $26.03 million -7.2%6.6%4.7 $11.22
3/15/20222,500,000 shares $24.88 million +4.2%7.1%5 $9.95
2/28/20222,400,000 shares $21.96 million -4.4%6.8%5 $9.15
2/15/20222,510,000 shares $22.82 million -12.5%7.1%5.1 $9.09
1/31/20222,870,000 shares $21.30 million +6.7%8.2%5.9 $7.42
1/15/20222,690,000 shares $15.47 million +3.5%N/A0 $5.75
12/31/20212,600,000 shares $16.93 million +12.1%7.2%6 $6.51
12/15/20212,320,000 shares $13.48 million +7.9%6.4%4.8 $5.81
11/30/20212,150,000 shares $11.91 million +1.9%6.0%4.3 $5.54
11/15/20212,110,000 shares $14.98 million -4.5%5.9%4.1 $7.10
10/29/20212,210,000 shares $17.28 million -11.6%6.1%4.2 $7.82
10/15/20212,500,000 shares $19.18 million +4.6%7.1%4.7 $7.67
9/30/20212,390,000 shares $18.21 million -1.2%6.8%4.6 $7.62
9/15/20212,420,000 shares $19.60 million -3.6%6.8%4.6 $8.10
Banks aren’t ready for this altcoin—are you? (Ad)

Crypto Market In Rare Form For Rapid Wealth Building When you've been in crypto as long as I have, you learn to recognize the signs and right now, I'm seeing something that's keeping me up at night.

Discover our #1 crypto for the red-hot crypto market right now!
8/31/20212,510,000 shares $26.61 million -21.6%7.7%4.7 $10.60
8/13/20213,200,000 shares $33.92 million -10.4%9.7%6.3 $10.60
7/30/20213,570,000 shares $38.63 million +1.7%10.7%6.4 $10.82
7/15/20213,510,000 shares $40.61 million +9.7%10.6%5.4 $11.57
6/30/20213,200,000 shares $40.48 million +13.1%9.7%4.1 $12.65
6/15/20212,830,000 shares $33.56 million -5.0%8.6%3.1 $11.86
5/28/20212,980,000 shares $32.24 million -19.9%9.0%3.1 $10.82
5/14/20213,720,000 shares $32.22 million +10.7%N/A3.4 $8.66
4/30/20213,360,000 shares $30.68 million -8.7%N/A2 $9.13
4/15/20213,680,000 shares $43.13 million +22.7%17.4%2.2 $11.72
3/31/20213,000,000 shares $35.25 million +2.0%15.5%1.9 $11.75
3/15/20212,940,000 shares $39.25 million -8.1%16.7%2 $13.35
2/26/20213,200,000 shares $36.80 million -3.3%22.4%2.1 $11.50
2/12/20213,310,000 shares $23.30 million -9.6%15.6%2.3 $7.04
1/29/20213,660,000 shares $23.94 million -11.4%17.2%4.6 $6.54
1/15/20214,130,000 shares $23.33 million +5.9%18.9%5.4 $5.65
12/31/20203,900,000 shares $13.26 million +5.1%17.8%6.1 $3.40
12/15/20203,710,000 shares $14.36 million -6.8%16.9%6.3 $3.87
11/30/20203,980,000 shares $15.24 million -0.5%18.2%9 $3.83
11/15/20204,000,000 shares $14.08 million +6.7%18.3%8.7 $3.52
10/30/20203,750,000 shares $10.95 million +8.7%17.1%8.9 $2.92
10/15/20203,450,000 shares $14.84 million +0.6%15.7%7.7 $4.30
9/30/20203,430,000 shares $13.41 million -15.3%15.6%0 $3.91
9/15/20204,050,000 shares $14.82 million -6.9%18.5%5.6 $3.66
8/31/20204,350,000 shares $16.79 million -6.7%19.8%5.8 $3.86
8/14/20204,660,000 shares $17.34 million -7.4%21.2%5 $3.72
7/31/20205,030,000 shares $16.40 million -4.2%22.9%4.4 $3.26
7/15/20205,250,000 shares $16.54 million -4.0%23.9%4.7 $3.15
6/30/20205,470,000 shares $28.99 million +9.4%24.9%5.1 $5.30
6/15/20205,000,000 shares $25.40 million +14.7%22.8%5.7 $5.08

EOLS Short Interest - Frequently Asked Questions

What is Evolus' current short interest?

Short interest is the volume of Evolus shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 9,670,000 shares of EOLS short. 16.26% of Evolus' shares are currently sold short. Learn More on Evolus' current short interest.

What is a good short interest ratio for Evolus?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EOLS shares currently have a short interest ratio of 10.0. Learn More on Evolus's short interest ratio.

Which institutional investors are shorting Evolus?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolus: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Evolus?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.26% of Evolus' floating shares are currently sold short.

Is Evolus' short interest increasing or decreasing?

Evolus saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 9,670,000 shares, an increase of 4.7% from the previous total of 9,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Evolus' short interest compare to its competitors?

16.26% of Evolus' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evolus: Apellis Pharmaceuticals, Inc. (21.59%), Xenon Pharmaceuticals Inc. (4.68%), Amneal Pharmaceuticals, Inc. (2.93%), Mirum Pharmaceuticals, Inc. (16.37%), Arrowhead Pharmaceuticals, Inc. (11.03%), NewAmsterdam Pharma (10.54%), Kiniksa Pharmaceuticals, Ltd. (8.29%), Vericel Co. (9.87%), Recursion Pharmaceuticals, Inc. (35.08%), Denali Therapeutics Inc. (9.72%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short Evolus stock?

Short selling EOLS is an investing strategy that aims to generate trading profit from Evolus as its price is falling. EOLS shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Evolus?

A short squeeze for Evolus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EOLS, which in turn drives the price of the stock up even further.

How often is Evolus' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EOLS, twice per month. The most recent reporting period available is May, 31 2025.




This page (NASDAQ:EOLS) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners